[1]张 丽,张 蕾,李 娜,等.妊娠期高血压患者血清circ-0002348和circ-0002814表达水平及其与妊娠结局相关性研究[J].陕西医学杂志,2025,54(2):197-200,204.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.010]
　ZHANG Li,ZHANG Lei,LI Na,et al.Expression levels of serum circ-0002348 and circ-0002814 in patients with hypertensive disorders of pregnancy and their correlation with pregnancy outcomes[J].,2025,54(2):197-200,204.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.010]
点击复制

妊娠期高血压患者血清circ-0002348和circ-0002814表达水平及其与妊娠结局相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年2期
页码:
197-200,204
栏目:
临床研究
出版日期:
2025-02-05

文章信息/Info

Title:
Expression levels of serum circ-0002348 and circ-0002814 in patients with hypertensive disorders of pregnancy and their correlation with pregnancy outcomes
作者:
张 丽1; 张 蕾1; 李 娜1; 高素英2
(1.石家庄市妇幼保健院产科,河北 石家庄 050000; 2.石家庄市妇幼保健院麻醉科,河北 石家庄 050000)
Author(s):
ZHANG Li1; ZHANG Lei1; LI Na1; GAO Suying2
(1.Department of Obstetrics,Shijiazhuang Maternal and Child Health Hospital,Shijiazhuang 050000,China; 2.Department of Anesthesiology,Shijiazhuang Maternal and Child Health Hospital,Shijiazhuang 050000,China)
关键词:
妊娠期高血压;  circ-0002348;  circ-0002814;  妊娠结局;  影响因素;  预测价值
Keywords:
Hypertensive disorders in pregnancy;  circ-0002348;  circ-0002814;  Pregnancy outcomes;  Influencing factors;  Predictive value
分类号:
R 714.252
DOI:
DOI:10.3969/j.issn.1000-7377.2025.02.010
文献标志码:
A
摘要:
目的:探讨妊娠期高血压患者血清circ-0002348和circ-0002814表达水平及其与妊娠结局的相关性。方法:选取妊娠期高血压患者90例为观察组,另选取同期健康孕妇79名为对照组。根据妊娠结局将患者分为妊娠结局不良组(18例)和妊娠结局良好组(72例)。采用RT-qPCR检测血清circ-0002348和circ-0002814表达水平。分析妊娠期高血压患者不良妊娠结局的影响因素。分析血清circ-0002348和circ-0002814对妊娠期高血压患者不良妊娠结局的预测价值。结果:观察组不良孕育史比例高于对照组(P<0.05)。与对照组比较,观察组血清circ-0002348表达水平升高,血清circ-0002814表达水平降低(均P<0.05)。与妊娠结局良好组比较,妊娠结局不良组患者不良孕育史比例更高,血清circ-0002348表达水平升高,血清circ-0002348表达水平降低(均P<0.05)。血清circ-000243和circ-0002814是妊娠期高血压患者不良妊娠结局的影响因素(均P<0.05)。血清circ-0002348和circ-0002814联合预测的曲线下面积(AUC)大于两者分别单独预测的AUC(均P<0.05)。结论:妊娠期高血压患者血清circ-000234高表达,血清circ-0002814低表达,与妊娠结局有关,两者联合对患者不良妊娠结局预测价值较高。
Abstract:
Objective:To investigate the expression levels of circ-0002348 and circ-0002814 in the serum of patients with hypertensive disorders in pregnancy and their correlation with pregnancy outcomes.Methods:A total of 90 patients with hypertensive disorders in pregnancy were selected as the observation group,and 79 healthy pregnant women during the same period were selected as the control group.Patients were divided into adverse pregnancy outcome group(18 cases)and favorable pregnancy outcome group(72 cases)based on pregnancy outcomes.RT-qPCR was used to detect the expression levels of serum circ-0002348 and circ-0002814.The influencing factors of adverse pregnancy outcomes in patients with hypertensive disorders in pregnancy were analyzed.The predictive value of serum circ-0002348 and circ-0002814 for adverse pregnancy outcomes in patients with hypertensive disorders in pregnancy was analyzed.Results:The proportion of adverse pregnancy histories in the observation group was higher than that in the control group(P<0.05).Compared with the control group,the expression level of serum circ-0002348 was increased,and the expression level of serum circ-0002814 was decreased in the observation group(all P<0.05).Compared with the favorable pregnancy outcome group,the adverse pregnancy outcome group had a higher proportion of adverse pregnancy histories,increased expression level of serum circ-0002348,and decreased expression level of serum circ-0002814(all P<0.05).Serum circ-0002348 and circ-0002814 were influencing factors for adverse pregnancy outcomes in patients with hypertensive disorders in pregnancy(all P<0.05).The combined predictive AUC of serum circ-0002348 and circ-0002814 was greater than the AUC of individual predictions(all P<0.05).Conclusion:High expression of serum circ-0002348 and low expression of serum circ-0002814 in patients with hypertensive disorders in pregnancy are related to pregnancy outcomes,and their combination has a high predictive value for adverse pregnancy outcomes.

参考文献/References:

[1] 王英梅,芦莉.妊娠期高血压疾病的预防研究进展[J].临床医学进展,2023,13(6):9718-9723.
[2] HE W,ZHANG Y,WU K,et al.Epigenetic phenotype of plasma cell-free DNA in the prediction of early-onset preeclampsia[J].J Obstet Gynaecol,2023,43(2):2282100.
[3] LI Q,REN X,WANG Y,et al.CircRNA:A rising star in leukemia[J].PeerJ,2023,11:e15577.
[4] 李琳,周蕾.环状RNA在心力衰竭中作用的研究进展[J].实用心脑肺血管病杂志,2023,31(5):125-128.
[5] CHEN L L.The expanding regulatory mechanisms and cellular functions of circular RNAs[J].Nat Rev Mol Cell Bio,2020,21(8):475-490.
[6] SAAOUD F,DRUMMER I V C,SHAO Y,et al.Circular RNAs are a novel type of non-coding RNAs in ROS regulation,cardiovascular metabolic infammations and cancers[J].Pharmacol Ther,2021,220:107715.
[7] ZHANG Y,YANG H,ZHANG Y,et al.CircCRAMP1L is a novel biomarker of preeclampsia risk and may play a role in preeclampsia pathogenesis via regulation of the MSP/RON axis in trophoblasts[J].BMC Pregnancy Childbirth,2020,20(1):652.
[8] ZHOU J,ZHAO Y,AN P,et al.Hsa_circ_0002348 regulates trophoblast proliferation and apoptosis through miR-126-3p/BAK1 axis in preeclampsia[J].J Transl Med,2023,21(1):509.
[9] 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南(2020)[J].中华妇产科杂志,2020,55(4):227-238.
[10] 魏青,梁茜,宋淑荣,等.早发型子痫前期的研究进展[J].中国城乡企业卫生,2022,7(6):37-42.
[11] 杨帆,高盼.血小板参数、D-二聚体在妊娠高血压综合征早期肾损伤患者中的表达及临床意义[J].陕西医学杂志,2021,50(4):413-416.
[12] 常鸿,张科伟,徐静,等.血清HbA1c、Alarin及Ficolin-3水平对妊娠期糖尿病患者妊娠结局的预测价值[J].天津医药,2024,52(6):625-629.
[13] 蒋晓颖,赵雪卉,张娟.妊娠高血压早期肾损伤情况及其与血清视黄醇结合蛋白、尿酸关系研究[J].陕西医学杂志,2021,50(2):151-153.
[14] 高蓉.解读临床干预治疗对妊娠期高血压疾病患者的血压和妊娠结局的影响[J].医药卫生,2022,22(10):4-8.
[15] 宋娟利.复方丹参注射液联合硫酸镁治疗妊娠期高血压疾病及对患者微炎症状态、肾功能的影响[J].陕西中医,2016,37(4):406-407.
[16] BISSON C,DAUTEL S,PATEL E,et al.Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum[J].Front Med(Lausanne),2023,10:1144170.
[17] 景蓉.益气养阴汤治疗妊娠期高血压综合征肾损害患者的临床疗效研究[J].陕西中医,2015(7):781-782.
[18] TENRIO M B,FERREIRA R C,MOURA F A,et al.Cross-talk between oxidative stress and inflammation in preeclampsia[J].Oxid Med Cell Longev,2019,2019:8238727.
[19] ABBAS R A,GHULMIYYAH L,HOBEIKA E,et al.Preeclampsia:A review of early predictors[J].Maternal-Fetal Med,2021,3(3):197-198.
[20] WEI L,LIU L,BAI M,et al.CircRNAs:Versatile players and new targets in organ fibrosis[J].Cell Commun Signal,2023,21(1):90.
[21] 刘浪,赵俞乔,关沧海,等.circ-ZNF609在肿瘤中的表达及作用机制[J].临床误诊误治,2021,34(11):113-116.
[22] 马严,姚牧笛,蒋沁,等.circRNA在眼部新生血管性疾病的研究进展[J].医学研究杂志,2021,50(4):140-143.
[23] WEI N,SONG H.Circ-0002814 participates in proliferation and migration through miR-210 and FUS/VEGF pathway of preeclampsia[J].J Obstet Gynaecol Res,2022,48(7):1698-1709.
[24] OU Y,ZHU L,WEI X,et al.Circular RNA circ_0111277 attenuates human trophoblast cell invasion and migration by regulating miR-494/HTRA1/Notch-1 signal pathway in pre-eclampsia[J].Cell Death Dis,2020,11(6):479.
[25] YE Y,LI M,CHEN L,et al.Circ-AK2 is associated with preeclampsia and regulates biological behaviors of trophoblast cells through miR-454-3p/THBS2[J].Placenta,2021,103:156-163.

相似文献/References:

[1]蒋永悟.妊娠期高血压患者尿蛋白和血常规水平分析及对妊娠结局的影响*[J].陕西医学杂志,2019,(1):128.
　JIANG Yongwu..Analysis of urinary protein and blood routine levels in patients with hypertensive disorder during pregnancy and its effect on pregnancy outcome[J].,2019,(2):128.
[2]冯思思,晋雅凌,邓科委△.妊娠期高血压胎儿预后及其与母体心脏形态功能相关性研究*[J].陕西医学杂志,2019,(12):1663.
[3]蒋晓颖,赵雪卉,张 娟.妊娠高血压早期肾损伤情况及其与血清视黄醇结合蛋白、尿酸关系研究[J].陕西医学杂志,2021,50(2):151.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.006]
　JIANG Xiaoying,ZHAO Xuehui,ZHANG Juan.Early renal injury in gestational hypertension and its relationship with serum sRBP and UA[J].,2021,50(2):151.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.006]
[4]陈园园,王利平.叶酸、维生素E联合硫酸镁治疗妊娠期高血压疗效及对患者血管内皮功能、Th1/Th2细胞水平的影响[J].陕西医学杂志,2021,50(2):208.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.021]
　CHEN Yuanyuan,WANG Liping.Efficacy of folic acid,vitamin E combined with magnesium sulfate in treatment of gestational hypertension and its effect on vascular endothelial function and Th1/Th2 cell level[J].,2021,50(2):208.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.021]

备注/Memo

备注/Memo:
[基金项目]河北省医学科学研究课题(20211762)
更新日期/Last Update: 2025-02-04